Unknown NA INTERVENTIONAL 2-arm NCT05856500

A Study of Creatine Combined With Curcumin in the Intervention of Early Cachexia in Upper Gastrointestinal Tumors

A Prospective Open Controlled Study of Creatine Combined With Curcumin in the Intervention of Early Cachexia in Upper Gastrointestinal Tumors

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Conditions Stage III Esophageal Cancer Stage IIIA Gastric Cancer Stage IIIB Gastric Cancer Stage IV Esophageal Cancer Stage IV Gastric Cancer

Interventions basic nutrition oral supplement of creatine and curcumin

Updated 4 times since 2023 Last updated: May 16, 2023 Started: Jun 1, 2023 Primary completion: Aug 31, 2025 Completion: Dec 31, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05856500, this NA trial focuses on Stage III Esophageal Cancer and Stage IIIA Gastric Cancer and remains ongoing. Sponsored by The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, it has been updated 4 times since 2023, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

4 versions recorded

Feb 2026 — Present [monthly]

Unknown NA

Status: Not Yet Recruiting → Unknown
Sep 2024 — Feb 2026 [monthly]

Not Yet Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting NA
Jun 2023 — Jul 2024 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Data source: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.